Literature DB >> 25219811

New considerations in radiation treatment planning for brain tumors: neural progenitor cell-containing niches.

Carmen Kut1, Kristin Janson Redmond2.   

Abstract

The purpose of this critical review is to explore the controversy regarding the relationship between radiation dose to the neural progenitor cell (NPC) niches and patient outcomes, in terms of both toxicity and tumor control. NPCs in the subventricular zone (SVZ) and hippocampus are paradoxically associated with long-term neurocognitive sequelae of brain irradiation, as well as resistance to therapy and tumor recurrence. The reconciliation of these somewhat opposing functions is challenging. Current literature suggests that radiation and other treatments against the NPC in the hippocampus and the SVZ may influence patient outcome. As a result, both the SVZ and the hippocampus could have important implications on radiation treatment planning strategies, and future laboratory and clinical evaluations will be critical in designing studies to optimize treatment outcome, effectiveness, and safety.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25219811      PMCID: PMC4467686          DOI: 10.1016/j.semradonc.2014.06.007

Source DB:  PubMed          Journal:  Semin Radiat Oncol        ISSN: 1053-4296            Impact factor:   5.934


  56 in total

1.  Factors influencing neurocognitive outcomes in young patients with benign and low-grade brain tumors treated with stereotactic conformal radiotherapy.

Authors:  Rakesh Jalali; Indranil Mallick; Debnarayan Dutta; Savita Goswami; Tejpal Gupta; Anusheel Munshi; Deepak Deshpande; Rajiv Sarin
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-10-26       Impact factor: 7.038

2.  Low cerebellar vermis volumes and impaired neuropsychologic performance in children treated for brain tumors and leukemia.

Authors:  A Horská; A Laclair; M Mohamed; C T Wells; T McNutt; K J Cohen; M Wharam; E M Mahone; W Kates
Journal:  AJNR Am J Neuroradiol       Date:  2010-05-06       Impact factor: 3.825

3.  Longitudinal evaluation of neurocognitive function after treatment for central nervous system germ cell tumors in childhood.

Authors:  Donald J Mabbott; Eric Monsalves; Brenda J Spiegler; Ute Bartels; Laura Janzen; Sharon Guger; Normand Laperriere; Nicole Andrews; Eric Bouffet
Journal:  Cancer       Date:  2011-05-11       Impact factor: 6.860

4.  Hippocampal-sparing whole-brain radiotherapy: a "how-to" technique using helical tomotherapy and linear accelerator-based intensity-modulated radiotherapy.

Authors:  Vinai Gondi; Ranjini Tolakanahalli; Minesh P Mehta; Dinesh Tewatia; Howard Rowley; John S Kuo; Deepak Khuntia; Wolfgang A Tomé
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-11-15       Impact factor: 7.038

Review 5.  Platelet-derived growth factor-mediated gliomagenesis and brain tumor recruitment.

Authors:  Elena I Fomchenko; Eric C Holland
Journal:  Neurosurg Clin N Am       Date:  2007-01       Impact factor: 2.509

6.  Can irradiation of potential cancer stem-cell niche in the subventricular zone influence survival in patients with newly diagnosed glioblastoma?

Authors:  Tejpal Gupta; Vimoj Nair; Siji Nojin Paul; Sadhana Kannan; Aliasgar Moiyadi; Sridhar Epari; Rakesh Jalali
Journal:  J Neurooncol       Date:  2012-05-04       Impact factor: 4.130

7.  L1CAM regulates DNA damage checkpoint response of glioblastoma stem cells through NBS1.

Authors:  Lin Cheng; Qiulian Wu; Zhi Huang; Olga A Guryanova; Qian Huang; Weinian Shou; Jeremy N Rich; Shideng Bao
Journal:  EMBO J       Date:  2011-02-04       Impact factor: 11.598

8.  A radiotherapy technique to limit dose to neural progenitor cell niches without compromising tumor coverage.

Authors:  Kristin J Redmond; Pragathi Achanta; Stuart A Grossman; Michael Armour; Juvenal Reyes; Lawrence Kleinberg; Erik Tryggestad; Alfredo Quinones-Hinojosa; Eric C Ford
Journal:  J Neurooncol       Date:  2011-02-14       Impact factor: 4.130

9.  Irradiation of the potential cancer stem cell niches in the adult brain improves progression-free survival of patients with malignant glioma.

Authors:  Patrick Evers; Percy P Lee; John DeMarco; Nzhde Agazaryan; James W Sayre; Michael Selch; Frank Pajonk
Journal:  BMC Cancer       Date:  2010-07-21       Impact factor: 4.430

10.  Region-specific radiotherapy and neuropsychological outcomes in adult survivors of childhood CNS malignancies.

Authors:  Gregory T Armstrong; Neelam Jain; Wei Liu; Thomas E Merchant; Marilyn Stovall; Deo Kumar Srivastava; James G Gurney; Roger J Packer; Leslie L Robison; Kevin R Krull
Journal:  Neuro Oncol       Date:  2010-08-17       Impact factor: 13.029

View more
  10 in total

1.  Glioblastoma recurrence patterns near neural stem cell regions.

Authors:  Linda Chen; Kaisorn L Chaichana; Lawrence Kleinberg; Xiaobu Ye; Alfredo Quinones-Hinojosa; Kristin Redmond
Journal:  Radiother Oncol       Date:  2015-08-11       Impact factor: 6.280

2.  A Prospective Cohort Study of Neural Progenitor Cell-Sparing Radiation Therapy Plus Temozolomide for Newly Diagnosed Patients With Glioblastoma.

Authors:  Chengcheng Gui; Tracy D Vannorsdall; Lawrence R Kleinberg; Ryan Assadi; Joseph A Moore; Chen Hu; Alfredo Quiñones-Hinojosa; Kristin J Redmond
Journal:  Neurosurgery       Date:  2020-07-01       Impact factor: 4.654

Review 3.  Neural stem cells, the subventricular zone and radiotherapy: implications for treating glioblastoma.

Authors:  Andrew W Smith; Minesh P Mehta; A Gabriella Wernicke
Journal:  J Neurooncol       Date:  2016-04-23       Impact factor: 4.130

4.  Repeatability of radiotherapy dose-painting prescriptions derived from a multiparametric magnetic resonance imaging model of glioblastoma infiltration.

Authors:  Caterina Brighi; Niels Verburg; Eng-Siew Koh; Amy Walker; Cathy Chen; Sugendran Pillay; Philip C de Witt Hamer; Farhannah Aly; Lois C Holloway; Paul J Keall; David E J Waddington
Journal:  Phys Imaging Radiat Oncol       Date:  2022-06-11

5.  Intensity-modulated proton therapy, volumetric-modulated arc therapy, and 3D conformal radiotherapy in anaplastic astrocytoma and glioblastoma : A dosimetric comparison.

Authors:  S Adeberg; S B Harrabi; N Bougatf; D Bernhardt; J Rieber; S A Koerber; M Syed; T Sprave; A Mohr; A Abdollahi; T Haberer; S E Combs; K Herfarth; J Debus; S Rieken
Journal:  Strahlenther Onkol       Date:  2016-06-22       Impact factor: 3.621

6.  Dose-escalated intensity-modulated radiotherapy and irradiation of subventricular zones in relation to tumor control outcomes of patients with glioblastoma multiforme.

Authors:  Grace Kusumawidjaja; Patricia Zhun Hong Gan; Whee Sze Ong; Achiraya Teyateeti; Pittaya Dankulchai; Daniel Yat Harn Tan; Eu Tiong Chua; Kevin Lee Min Chua; Chee Kian Tham; Fuh Yong Wong; Melvin Lee Kiang Chua
Journal:  Onco Targets Ther       Date:  2016-03-02       Impact factor: 4.147

Review 7.  The Role of Wnt Signal in Glioblastoma Development and Progression: A Possible New Pharmacological Target for the Therapy of This Tumor.

Authors:  Mariachiara Zuccarini; Patricia Giuliani; Sihana Ziberi; Marzia Carluccio; Patrizia Di Iorio; Francesco Caciagli; Renata Ciccarelli
Journal:  Genes (Basel)       Date:  2018-02-17       Impact factor: 4.096

8.  Asymptomatic Evolution and Regression of Temporal Lobe Necrosis After Adjuvant Radiation for Skin Cancer: A Case Report and Review of Literature.

Authors:  Rima Pathak; Gaurav Bahl
Journal:  Cureus       Date:  2016-02-05

9.  Dosimetric advantages of proton therapy over conventional radiotherapy with photons in young patients and adults with low-grade glioma.

Authors:  S B Harrabi; N Bougatf; A Mohr; T Haberer; K Herfarth; S E Combs; J Debus; S Adeberg
Journal:  Strahlenther Onkol       Date:  2016-06-30       Impact factor: 3.621

10.  Dosimetric Comparison of Proton Radiation Therapy, Volumetric Modulated Arc Therapy, and Three-Dimensional Conformal Radiotherapy Based on Intracranial Tumor Location.

Authors:  Sebastian Adeberg; Semi B Harrabi; Nina Bougatf; Vivek Verma; Paul Windisch; Denise Bernhardt; Stephanie E Combs; Klaus Herfarth; Juergen Debus; Stefan Rieken
Journal:  Cancers (Basel)       Date:  2018-10-26       Impact factor: 6.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.